circ_0039787 promotes cervical cancer cell tumorigenesis by regulation of the miR-877-5p-KRAS axis

被引:0
作者
He, Xiuchao [1 ]
Sun, Jing [2 ]
Zhang, Jing [1 ]
Zhu, Binbin [1 ]
Jin, Lufei [1 ]
Wang, Jianhua [1 ]
Guan, Qingyan [2 ]
机构
[1] Ningbo Univ, Affiliated Hosp 1, Dept Radiol, Ningbo, Zhejiang, Peoples R China
[2] Yinzhou 2 Hosp Ningbo, Dept Gynecol & Obstet, Ningbo, Zhejiang, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 03期
关键词
circRNAs; cervical carcinoma; circ_0039787; miR-877-5p; KRAS; MICRORNA; PROLIFERATION; PROGRESSION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Circular RNA (circRNA) is a novel type of RNA that plays an important role in the occurrence and development of many malignant tumors. However, the potential regulatory role and molecular mechanisms of circRNAs in cervical cancer (CC) are still not clear. Here, we explored circRNAs associated with CC from the Gene Expression Omnibus (GEO) datasets GSE113696 and GSE102686. We initially identified circ_0039787, which is derived from exons 2 to 3 of the C16orf70 gene. We observed that circ_0039787 is mainly located in the cytoplasm and is more stable than its linear counterpart, C16orf70. circ_0039787 is significantly upregulated in CC tissues and cells. In addition, functional gain and loss experiments demonstrated that circ_0039787 promotes the proliferation, migration, and invasion of CC cells in vitro and the growth of CC tumors in vivo. Mechanistically, circ_0039787 promotes CC tumor progression by competitively absorbing miR-877-5p to alleviate the inhibitory effect of miR-877-5p on Kirsten Rat Sarcoma viral oncogene homolog (KRAS) expression. Overall, our results suggest that circ_0039787 could serve as a promising diagnostic biomarker and potential therapeutic target for CC patients.
引用
收藏
页码:2736 / 2752
页数:17
相关论文
共 31 条
  • [1] Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients
    Baldasici, Oana
    Balacescu, Loredana
    Cruceriu, Daniel
    Roman, Andrei
    Lisencu, Carmen
    Fetica, Bogdan
    Visan, Simona
    Cismaru, Andrei
    Jurj, Ancuta
    Barbu-Tudoran, Lucian
    Pileczki, Valentina
    Vlase, Laurian
    Tudoran, Oana
    Balacescu, Ovidiu
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [2] Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications
    Bumrungthai, Sureewan
    Munjal, Kavita
    Nandekar, Shirish
    Cooper, Kumarasen
    Ekalaksananan, Tipaya
    Pientong, Chamsai
    Evans, Mark Francis
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [3] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [4] Cervical cancer prevention and control in women living with human immunodeficiency virus
    Castle, Philip E.
    Einstein, Mark H.
    Sahasrabuddhe, Vikrant V.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (06) : 505 - 526
  • [5] Cervical cancer
    Cohen, Paul A.
    Jhingran, Anjua
    Oaknin, Ana
    Denny, Lynette
    [J]. LANCET, 2019, 393 (10167) : 169 - 182
  • [6] MiR-16 inhibits proliferation of cervical cancer cells by regulating KRAS
    Ding, Z.
    Liu, S-J
    Liu, X-W
    Ma, Q.
    Qiao, Z.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (20) : 10419 - 10425
  • [7] Targeting the MAPK Pathway in KRAS-Driven Tumors
    Drosten, Matthias
    Barbacid, Mariano
    [J]. CANCER CELL, 2020, 37 (04) : 543 - 550
  • [8] MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1
    Feng, Sijie
    Lu, Yunkun
    Sun, Lisha
    Hao, Shuangying
    Liu, Zhiqiang
    Yang, Fangyuan
    Zhang, Lin
    Wang, Ting
    Jiang, Lihong
    Zhang, Juan
    Liu, Shuyan
    Pang, Hui
    Wang, Zhenhui
    Wang, Hong
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (21)
  • [9] Targeting microRNAs in cancer: rationale, strategies and challenges
    Garzon, Ramiro
    Marcucci, Guido
    Croce, Carlo M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (10) : 775 - 789
  • [10] The end of the beginning: progress and next steps in KRAS-mutant non-small-cell lung cancer
    Goldberg, Sarah B.
    Herbst, Roy S.
    [J]. LANCET, 2023, 401 (10378) : 706 - 707